Helping You Find Full Text Journal Articles

Apr
2014

Matrix Gla protein (MGP) is an important inhibitor of calcification. The objective of the present study of patients with type 2 diabetes and normal or slightly altered kidney function was to evaluate levels of inactive, dephospho-uncarboxylated MGP(dp-ucMGP) and total uncarboxylated MGP(t-ucMGP) and assess their links with biological and clinical parameters (including peripheral vascular calcification).
The DIACART study is a cross-sectional cohort study of 198 patients with type 2 diabetes and normal or slightly altered kidney function.
Full Text Link Source Status
https://pdfs.semanticscholar.org/6d1d/1991a49dba0beb00ad48d2
Web SearchFound
http://www.biomedcentral.com/content/pdf/1475-2840-13-85.pdf
Web SearchFound
https://pdfs.semanticscholar.org/aa74/4e6780236159012bd3f9c9
Web SearchFound
http://cardiab.biomedcentral.com/articles/10.1186/1475-2840-
Publisher SiteFound
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017083PMCFound


Similar Publications

Sep
2014

Matrix Gla protein (MGP) is known to act as a potent local inhibitor of vascular calcifications. However, in order to be active, MGP must be phosphorylated and carboxylated, with this last process being dependent on vitamin K. The present study focused on the inactive form of MGP (dephosphorylated and uncarboxylated: dp-ucMGP) in a population of hemodialyzed (HD) patients.

View Full Text PDF Listings View primary source full text article PDFs.

Dec
2017

Matrix Gla protein (MGP) is a potent inhibitor of vascular calcification and needs vitamin K-dependent carboxylation for its activity. High levels of desphosphorylated uncarboxylated MGP (dp-ucMGP) were significantly associated with vitamin K deficiency and vascular calcification. This study was conducted to explore the correlations of plasma dp-ucMGP with vascular calcification and vascular stiffness in chronic kidney disease (CKD) patients.

View Full Text PDF Listings View primary source full text article PDFs.

Apr
2010

Vitamin K-dependent matrix Gla protein (MGP) acts as a calcification inhibitor in vitro and in vivo. The present study was performed to (1) determine plasma levels of the inactive, dephosphorylated, uncarboxylated MGP (dp-ucMGP) in a cohort of patients at different stages of chronic kidney disease (CKD) and (2) evaluate the association between dp-ucMGP levels on one hand and aortic calcification and mortality on the other.
107 patients (67 +/- 13 years; 60% male; 32% at CKD stages 2 to 3, 31% at stages 4 to 5, 37% at stage 5D) were assayed for dp-ucMGP and underwent multislice spiral computed tomography scans to quantify aortic calcification at baseline.

View Full Text PDF Listings View primary source full text article PDFs.

Apr
2013

Matrix Gla protein (MGP) is a vitamin K-dependent protein and an inhibitor of vascular calcification. Vitamin K is required for the carboxylation of MGP and can thereby reduce calcification. Circulating MGP species with different conformations have been investigated as markers for coronary artery calcification (CAC).

View Full Text PDF Listings View primary source full text article PDFs.
Back to top